331 related articles for article (PubMed ID: 35669772)
1. Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy.
Bhat J; Placek K; Faissner S
Front Immunol; 2022; 13():894580. PubMed ID: 35669772
[TBL] [Abstract][Full Text] [Related]
2. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
Ma R; Yuan D; Guo Y; Yan R; Li K
Front Immunol; 2020; 11():1600. PubMed ID: 33013819
[TBL] [Abstract][Full Text] [Related]
3. γδ T cell exhaustion: Opportunities for intervention.
Chen D; Guo Y; Jiang J; Wu P; Zhang T; Wei Q; Huang J; Wu D
J Leukoc Biol; 2022 Dec; 112(6):1669-1676. PubMed ID: 36000310
[TBL] [Abstract][Full Text] [Related]
4. Editorial: γδ T Cells in Cancer.
Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I
Front Immunol; 2020; 11():602411. PubMed ID: 33329597
[No Abstract] [Full Text] [Related]
5. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
Lopes N; Silva-Santos B
Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
[TBL] [Abstract][Full Text] [Related]
6. A close look at current γδ T-cell immunotherapy.
Ma L; Feng Y; Zhou Z
Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
[TBL] [Abstract][Full Text] [Related]
7. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
Paul S; Lal G
Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
[TBL] [Abstract][Full Text] [Related]
8. Gamma/delta T cells as cellular vehicles for anti-tumor immunity.
Wang CQ; Lim PY; Tan AH
Front Immunol; 2023; 14():1282758. PubMed ID: 38274800
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic avenues for γδ T cells in cancer.
Costa GP; Mensurado S; Silva-Santos B
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007241
[TBL] [Abstract][Full Text] [Related]
10. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.
Chitadze G; Oberg HH; Wesch D; Kabelitz D
Trends Immunol; 2017 Sep; 38(9):668-678. PubMed ID: 28709825
[TBL] [Abstract][Full Text] [Related]
11. Current progress in γδ T-cell biology.
Hao J; Wu X; Xia S; Li Z; Wen T; Zhao N; Wu Z; Wang P; Zhao L; Yin Z
Cell Mol Immunol; 2010 Nov; 7(6):409-13. PubMed ID: 21042298
[TBL] [Abstract][Full Text] [Related]
12. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
13. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
14. γδ T cells in oral diseases.
Wei XY; Tan YQ; Zhou G
Inflamm Res; 2024 May; 73(5):867-876. PubMed ID: 38563967
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytokine producing activity of intestinal intraepithelial T cells from TCR beta-chain and delta-chain mutant mice.
Kohyama M; Hachimura S; Nanno M; Ishikawa H; Kaminogawa S
Microbiol Immunol; 1997; 41(4):353-9. PubMed ID: 9159410
[TBL] [Abstract][Full Text] [Related]
16. γδ T cells: origin and fate, subsets, diseases and immunotherapy.
Hu Y; Hu Q; Li Y; Lu L; Xiang Z; Yin Z; Kabelitz D; Wu Y
Signal Transduct Target Ther; 2023 Nov; 8(1):434. PubMed ID: 37989744
[TBL] [Abstract][Full Text] [Related]
17. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
[TBL] [Abstract][Full Text] [Related]
18. Recognition of the antigen-presenting molecule MR1 by a Vδ3
Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
[TBL] [Abstract][Full Text] [Related]
19. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
Liu Y; Zhang C
Cells; 2020 May; 9(5):. PubMed ID: 32413966
[TBL] [Abstract][Full Text] [Related]
20. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.
Brandes M; Willimann K; Bioley G; Lévy N; Eberl M; Luo M; Tampé R; Lévy F; Romero P; Moser B
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2307-12. PubMed ID: 19171897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
